News
$Gritstone Bio (GRTS.US)$ Reuters· just
Gritstone bio Announces Interim Phase 2 Data for Granite Individualized Neoantigen Targeting Immunotherapy in Frontline Metastatic Microsatellite Stable Colorectal Cancer! Well tolerated with no advers events
Gritstone bio Announces Interim Phase 2 Data for Granite Individualized Neoantigen Targeting Immunotherapy in Frontline Metastatic Microsatellite Stable Colorectal Cancer! Well tolerated with no advers events
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Rich365 : That sounds like good news to me.
Trytosaveabit OP Rich365 : Yeah it’s pretty good!
J Tan88 : Good news , but share drop , hopefully this company violated the minimum bid price requirement.
Trytosaveabit OP J Tan88 : They have until December to get above 1.00! If they don’t? They may get another 180 days to regain compliance?
J Tan88 : All time low price! Grab some
Trytosaveabit OP J Tan88 : I’m looking to! Wanna see where it goes today first! GL